Predictive factors for the efficacy of abiraterone acetate therapy in high-risk metastatic hormone-sensitive prostate cancer patients.

Takashi UedaKazutoshi FujitaMitsuhisa NishimotoTakumi ShiraishiMasatsugu MiyashitaNaruhiro KayukawaYuichi NakamuraSatoshi SakoRyota OguraAtsuko FujiharaTakafumi MinamiFumiya HongoKoji OkiharaKazuhiro YoshimuraHirotsugu UemuraOsamu Ukimura

Published in: World journal of urology (2022)

The presence of Gleason pattern 5 at the primary lesion may be a predictor for high-risk mHSPC patients who could benefit from abiraterone acetate treatment.

Keyphrases

prostate cancer
squamous cell carcinoma
small cell lung cancer
radical prostatectomy
replacement therapy
combination therapy
bone marrow